WallStreetZenWallStreetZen

NASDAQ: ANAB
Anaptysbio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ANAB

Based on 7 analysts offering 12 month price targets for Anaptysbio Inc

Min Forecast
$60.00+18.81%
Avg Forecast
$78.57+55.59%
Max Forecast
$95.00+88.12%

Should I buy or sell ANAB stock?

Based on 7 analysts offering ratings for Anaptysbio Inc.

Strong Buy
Strong Buy
5 analysts 71.43%
Buy
2 analysts 28.57%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ANAB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ANAB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their ANAB stock forecasts and price targets.

ANAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-30
lockedlocked$00.00+00.00%2026-09-24
lockedlocked$00.00+00.00%2026-09-23
lockedlocked$00.00+00.00%2026-08-25
lockedlocked$00.00+00.00%2026-05-13
Barclays
Top 2%
99
Strong BuyMaintains$75.00+48.51%2026-05-13Find out why
Piper Sandler
Top 6%
95
Strong BuyMaintains$93.00+84.16%2026-05-04

1 of 1

Forecast return on equity

Is ANAB forecast to generate an efficient return?

Company
2,745.39%
Industry
21.59%
Market
175.56%
ANAB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANAB forecast to generate an efficient return on assets?

Company
91.68%
Industry
22.9%
ANAB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANAB earnings per share forecast

What is ANAB's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$0.62-109.15%
Avg 2 year Forecast
$6.73-0.41%
Avg 3 year Forecast
$1.84-72.84%
ANAB's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ANAB revenue forecast

What is ANAB's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$156.2M-34.25%
Avg 2 year Forecast
$192.7M-18.9%
Avg 3 year Forecast
$210.5M-11.41%
ANAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ANAB earnings growth forecast

How is ANAB forecast to perform vs Biotechnology companies and vs the US market?

Company
-35.24%
Industry
11.16%
Market
32.47%
ANAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ANAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ANAB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ANAB revenue growth forecast

How is ANAB forecast to perform vs Biotechnology companies and vs the US market?

Company
-3.96%
Industry
31.06%
Market
13.36%
ANAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANAB$50.50$78.57+55.59%Strong Buy
REPL$16.06$19.00+18.31%Strong Buy
INVA$21.12$39.25+85.84%Strong Buy
GPCR$21.48$92.33+329.86%Strong Buy
GHRS$20.71$44.50+114.87%Strong Buy
View Top Biotech Stocks

Anaptysbio Stock Forecast FAQ

Is Anaptysbio Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: ANAB) stock is to Strong Buy ANAB stock.

Out of 7 analysts, 5 (71.43%) are recommending ANAB as a Strong Buy, 2 (28.57%) are recommending ANAB as a Buy, 0 (0%) are recommending ANAB as a Hold, 0 (0%) are recommending ANAB as a Sell, and 0 (0%) are recommending ANAB as a Strong Sell.

If you're new to stock investing, here's how to buy Anaptysbio stock.

What is ANAB's earnings growth forecast for 2026-2027?

(NASDAQ: ANAB) Anaptysbio's forecast annual earnings growth rate of -35.24% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.47%.

Anaptysbio's earnings in 2026 is $195,723,000.On average, 11 Wall Street analysts forecast ANAB's earnings for 2026 to be -$18,493,198, with the lowest ANAB earnings forecast at -$157,326,711, and the highest ANAB earnings forecast at $141,882,828. On average, 4 Wall Street analysts forecast ANAB's earnings for 2027 to be $201,254,783, with the lowest ANAB earnings forecast at $126,271,532, and the highest ANAB earnings forecast at $279,057,155.

In 2027, ANAB is forecast to generate $54,887,668 in earnings, with the lowest earnings forecast at -$149,709,403 and the highest earnings forecast at $172,017,234.

What is ANAB's revenue growth forecast for 2026-2027?

(NASDAQ: ANAB) Anaptysbio's forecast annual revenue growth rate of -3.96% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.36%.

Anaptysbio's revenue in 2026 is $237,613,000.On average, 11 Wall Street analysts forecast ANAB's revenue for 2026 to be $4,670,832,923, with the lowest ANAB revenue forecast at $3,263,663,787, and the highest ANAB revenue forecast at $5,998,779,661. On average, 5 Wall Street analysts forecast ANAB's revenue for 2027 to be $5,761,112,471, with the lowest ANAB revenue forecast at $4,822,401,810, and the highest ANAB revenue forecast at $6,403,561,265.

In 2027, ANAB is forecast to generate $6,292,948,862 in revenue, with the lowest revenue forecast at $4,617,320,436 and the highest revenue forecast at $7,847,501,550.

What is ANAB's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ANAB) forecast ROA is 91.68%, which is higher than the forecast US Biotechnology industry average of 22.9%.

What is ANAB's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ANAB price target, the average ANAB price target is $78.57, with the highest ANAB stock price forecast at $95.00 and the lowest ANAB stock price forecast at $60.00.

On average, Wall Street analysts predict that Anaptysbio's share price could reach $78.57 by Sep 30, 2027. The average Anaptysbio stock price prediction forecasts a potential upside of 55.59% from the current ANAB share price of $50.50.

What is ANAB's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: ANAB) Anaptysbio's current Earnings Per Share (EPS) is $6.76. On average, analysts forecast that ANAB's EPS will be -$0.62 for 2026, with the lowest EPS forecast at -$5.26, and the highest EPS forecast at $4.75. On average, analysts forecast that ANAB's EPS will be $6.73 for 2027, with the lowest EPS forecast at $4.22, and the highest EPS forecast at $9.33. In 2027, ANAB's EPS is forecast to hit $1.84 (min: -$5.01, max: $5.75).

What is ANAB's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ANAB) forecast ROE is 2,745.39%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.